Publications
- Treatment strategy of triple negative breast cancer in young women - do we treat them differently?2023 | First Faculty of Medicine
- Multimodal approach in the treatment of generalized malignancies of the gastrointestinal tract2022 | First Faculty of Medicine
- Treatment of HER2-positive breast cancer in 20202020 | First Faculty of Medicine
- Use of Trastuzumab for Neoadjuvant Therapy of HER2+ Breast Cancer - 5-Years of Experience in a Single Clinic2018 | First Faculty of Medicine
- Molecular characterization and heterogeneity of circulating tumor cells in breast cancer2017 | First Faculty of Medicine, Central Library of Charles University
- Therapeutic algorithm for pancreatic cancer - can we expect improved survival in near future?2016 | First Faculty of Medicine
- Circulating Tumor Cells in Patients with Breast Cancer: Monitoring Chemotherapy Success2014 | First Faculty of Medicine, Third Faculty of Medicine
- Changes in the presence of circulating tumor cells in the peripheral blood of breast cancer patients during the course of treatmentPublication without faculty affiliation
- Mitochondrially targeted tamoxifen in patients with metastatic solid tumours: an open-label, phase I/Ib single-centre trial2023 | First Faculty of Medicine, Third Faculty of Medicine, Central Library of Charles University, Faculty of Science, Faculty of Mathematics and Physics
- Mitochondrially targeted tamoxifen as anticancer therapy: case series of patients with renal cell carcinoma treated in a phase I/Ib clinical trial2023 | First Faculty of Medicine, Third Faculty of Medicine, Central Library of Charles University, Faculty of Science, Faculty of Mathematics and Physics
Loading network view...
